Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
24.9 USD | -5.66% | -.--% | +0.22% |
Business Summary
Number of employees: 11,603
Sales per Business
HUF in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Women's Healthcare
31.8
%
| - | - | 255,673 | 31.8 % | - |
General Medicines
28.2
%
| - | - | 226,888 | 28.2 % | - |
Neuropsychiatry
25.5
%
| - | - | 205,662 | 25.5 % | - |
Other
8.8
%
| 1,024 | 0.1 % | 70,874 | 8.8 % | +6,821.29% |
Biotechnology
5.7
%
| - | - | 46,201 | 5.7 % | - |
Eliminations
-1.6
%
| 0 | 0.0 % | -13,162 | -1.6 % | - |
Pharma Other
1.6
%
| - | - | 13,022 | 1.6 % | - |
Sales per region
HUF in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
26.9
%
| 162,148 | 20.2 % | 216,824 | 26.9 % | +33.72% |
Europe
19.6
%
| 0 | 0.0 % | 157,899 | 19.6 % | - |
Russia
14.5
%
| 129,066 | 16.1 % | 116,893 | 14.5 % | -9.43% |
Hungary
6.5
%
| 46,624 | 5.8 % | 52,170 | 6.5 % | +11.90% |
Poland
4.4
%
| 32,324 | 4.0 % | 35,595 | 4.4 % | +10.12% |
Germany
3.6
%
| 26,194 | 3.3 % | 28,938 | 3.6 % | +10.48% |
Spain
3.0
%
| 20,696 | 2.6 % | 24,039 | 3.0 % | +16.15% |
China
3.0
%
| 21,712 | 2.7 % | 24,025 | 3.0 % | +10.65% |
Latin America
2.9
%
| 27,882 | 3.5 % | 23,039 | 2.9 % | -17.37% |
Asia Pacific
2.4
%
| - | - | 19,042 | 2.4 % | - |
Romania
2.2
%
| 14,992 | 1.9 % | 17,581 | 2.2 % | +17.27% |
Italy
2.0
%
| 14,724 | 1.8 % | 16,475 | 2.0 % | +11.89% |
France
1.9
%
| 14,790 | 1.8 % | 15,624 | 1.9 % | +5.64% |
United Kingdom
1.6
%
| - | - | 12,778 | 1.6 % | - |
Mexico
1.1
%
| - | - | 8,644 | 1.1 % | - |
Kazakhstan
1.0
%
| - | - | 8,401 | 1.0 % | - |
Rest of World
1.0
%
| 36,500 | 4.5 % | 8,262 | 1.0 % | -77.36% |
Uzbekistan
0.9
%
| - | - | 7,374 | 0.9 % | - |
Ukraine
0.9
%
| 10,518 | 1.3 % | 7,189 | 0.9 % | -31.65% |
North America
0.5
%
| - | - | 4,366 | 0.5 % | - |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Gábor Orbán
CEO | Chief Executive Officer | 45 | - |
István Hamecz
DFI | Director of Finance/CFO | 57 | 21-12-31 |
Istvan Greiner
CTO | Chief Tech/Sci/R&D Officer | 64 | 83-12-31 |
Erik Bogsch
BRD | Director/Board Member | 76 | 69-12-31 |
Adam Demeter
PRN | Corporate Officer/Principal | - | - |
Katalin Erdei
HRO | Human Resources Officer | - | 18-03-31 |
Tibor Horváth
SAM | Sales & Marketing | 50 | 16-12-31 |
György Thaler
PRN | Corporate Officer/Principal | 65 | 82-12-31 |
Lajos Kovács
PRN | Corporate Officer/Principal | 63 | 83-12-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Erik Bogsch
BRD | Director/Board Member | 76 | 69-12-31 |
Szilveszter Vizi
CHM | Chairman | 88 | 07-12-31 |
Director/Board Member | 63 | 12-04-25 | |
Gabriella Balogh
BRD | Director/Board Member | - | - |
Ilona Hardy
BRD | Director/Board Member | 68 | 17-04-25 |
Anett Pandurics
BRD | Director/Board Member | 51 | 18-04-24 |
Péter Cserháti
BRD | Director/Board Member | 61 | 20-04-27 |
Livia Pavlik
CHM | Chairman | - | 21-04-14 |
Ferenc Sallai
BRD | Director/Board Member | - | 22-12-31 |
Laszlo Nemeth
BRD | Director/Board Member | - | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 186,374,860 | 135,441,267 ( 72.67 %) | 3,880,963 ( 2.082 %) | 72.67 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
GEDEON RICHTER 2.08% | 3,877,941 | 2.08% | 98,218,240 $ |
Company contact information
Chemical Works of Gedeon Richter Plc
Gyömrõi út 19-21
1103, Budapest
+36 1 431 4000
http://www.richter.huSector
Sales per Business
Sales per region
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+24.53% | 45.07B | |
+30.99% | 23.39B | |
+24.13% | 16.08B | |
+21.15% | 14.6B | |
+68.67% | 14.01B | |
-0.05% | 6.79B | |
-13.29% | 6.38B | |
-8.87% | 5.73B | |
+13.53% | 5.64B |
- Stock Market
- Equities
- RICHTER Stock
- RGED.F Stock
- Company Gedeon Richter